Abbott (ABT) acquires Cardiovascular Systems (CSII) in 'brilliant move'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cardiovascular Systems (CSII) PT Raised to $20 at Stifel
February 9, 2023 8:07 AM ESTStifel analyst Mathew Blackman raised the price target on Cardiovascular Systems (NASDAQ: CSII) to $20.00 (from $18.00) while maintaining a Hold rating.... More
Lake Street Capital Markets Downgrades Cardiovascular Systems (CSII) to Sell
February 9, 2023 7:43 AM ESTLake Street Capital Markets analyst Brooks O'neil downgraded Cardiovascular Systems (NASDAQ: CSII) from Hold to Sell.
For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.
Shares of Cardiovascular Systems closed at $13.31 yesterday.
... MoreAbbott (ABT) to acquire Cardiovascular Systems (CSII) for $20/share
February 9, 2023 6:22 AM ESTAbbott (NYSE: ABT) and Cardiovascular Systems, Inc. (NASDAQ: CSII), today announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million.
CSI is a leader in devices for... More
Cardiovascular Systems (CSII) Misses Q2 EPS by 5c
February 9, 2023 4:50 AM ESTCardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.20), $0.05 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $61.5 million versus the consensus estimate of $63.06 million.
For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.
... More